Theresa Gilewski - Concepedia

Author

Theresa Gilewski

Also Known As

T A Gilewski, T Gilewski, T. Gilewski, T.A. Gilewski, THERESA A. GILEWSKI, THERESA GILEWSKI, Theresa A. Gilewski, Theresa Gilewski

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University University of Chicago

About

Theresa Gilewski is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	305
2	Pharmacology	3	3	151
3	Pathology	2	2	154
4	Public Health	1	1	66
5	Obstetrics	1	1	66

Theresa Gilewski

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
BRCA-associated breast cancer in young women. Mark E. Robson, Theresa Gilewski, Bruce R. Haas, Journal of Clinical Oncology	1998	303
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. Andrew D. Seidman, Bonnie Reichman, John Crown, Journal of Clinical Oncology	1995	205
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. Andrew D. Seidman, Daniel Hochhauser, M Gollub, Journal of Clinical Oncology	1996	152
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. S F Williams, Theresa Gilewski, Rosemarie Mick, Journal of Clinical Oncology	1992	133
Effect of Adjuvant Tamoxifen on the Endometrium in Women With Breast Cancer: A Prospective Study Using Office Endometrial Biopsy R.R. Barakat, Theresa Gilewski, Lois Almadrones, Journal of Clinical Oncology	2000	114
BRCA-associated breast cancer: absence of a characteristic immunophenotype. Marc E Robson, P Rajan, Peter Rosen, PubMed Breast OncologyMedicineGeneticsPathologyBrca-associated Breast Cancer	1998	88
Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Chau T. Dang, Neil M. Iyengar, Farrah Mikhail Datko, Journal of Clinical Oncology	2014	78
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer Monica Fornier, Patrick G. Morris, A. Abbruzzi, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicinePharmacologyWeekly Paclitaxel	2011	70
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. John Crown, A. Kritz, Linda T. Vahdat, Journal of Clinical Oncology	1993	70
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer Patrick G. Morris, Selene Rota, Karen A. Cadoo, Clinical Breast Cancer Metastatic Breast CancerOncologyBreast OncologyMedicinePhase Ii Study	2018	67

Page 1